2650 related articles for article (PubMed ID: 10635029)
1. The role of oligodendrocytes and oligodendrocyte progenitors in CNS remyelination.
Keirstead HS; Blakemore WF
Adv Exp Med Biol; 1999; 468():183-97. PubMed ID: 10635029
[TBL] [Abstract][Full Text] [Related]
2. The origin of remyelinating cells in the central nervous system.
Blakemore WF; Keirstead HS
J Neuroimmunol; 1999 Jul; 98(1):69-76. PubMed ID: 10426364
[TBL] [Abstract][Full Text] [Related]
3. Inflammation stimulates remyelination in areas of chronic demyelination.
Foote AK; Blakemore WF
Brain; 2005 Mar; 128(Pt 3):528-39. PubMed ID: 15699059
[TBL] [Abstract][Full Text] [Related]
4. The remyelinating potential and in vitro differentiation of MOG-expressing oligodendrocyte precursors isolated from the adult rat CNS.
Crang AJ; Gilson JM; Li WW; Blakemore WF
Eur J Neurosci; 2004 Sep; 20(6):1445-60. PubMed ID: 15355312
[TBL] [Abstract][Full Text] [Related]
5. Impaired remyelination and depletion of oligodendrocyte progenitors does not occur following repeated episodes of focal demyelination in the rat central nervous system.
Penderis J; Shields SA; Franklin RJ
Brain; 2003 Jun; 126(Pt 6):1382-91. PubMed ID: 12764059
[TBL] [Abstract][Full Text] [Related]
6. Do central nervous system axons remyelinate?
Nait-Oumesmar B; Lachapelle F; Decker L; Baron-Van Evercooren A
Pathol Biol (Paris); 2000 Feb; 48(1):70-9. PubMed ID: 10729914
[TBL] [Abstract][Full Text] [Related]
7. Mechanisms of remyelination: recent insight from experimental models.
Tanaka T; Yoshida S
Biomol Concepts; 2014 Aug; 5(4):289-98. PubMed ID: 25372760
[TBL] [Abstract][Full Text] [Related]
8. Local recruitment of remyelinating cells in the repair of demyelination in the central nervous system.
Franklin RJ; Gilson JM; Blakemore WF
J Neurosci Res; 1997 Oct; 50(2):337-44. PubMed ID: 9373042
[TBL] [Abstract][Full Text] [Related]
9. Identification of post-mitotic oligodendrocytes incapable of remyelination within the demyelinated adult spinal cord.
Keirstead HS; Blakemore WF
J Neuropathol Exp Neurol; 1997 Nov; 56(11):1191-201. PubMed ID: 9370229
[TBL] [Abstract][Full Text] [Related]
10. The adult oligodendrocyte can participate in remyelination.
Duncan ID; Radcliff AB; Heidari M; Kidd G; August BK; Wierenga LA
Proc Natl Acad Sci U S A; 2018 Dec; 115(50):E11807-E11816. PubMed ID: 30487224
[TBL] [Abstract][Full Text] [Related]
11. Cells of the oligodendroglial lineage, myelination, and remyelination.
Miron VE; Kuhlmann T; Antel JP
Biochim Biophys Acta; 2011 Feb; 1812(2):184-93. PubMed ID: 20887785
[TBL] [Abstract][Full Text] [Related]
12. Remyelination in multiple sclerosis: cellular mechanisms and novel therapeutic approaches.
Olsen JA; Akirav EM
J Neurosci Res; 2015 May; 93(5):687-96. PubMed ID: 25287108
[TBL] [Abstract][Full Text] [Related]
13. The response of NG2-expressing oligodendrocyte progenitors to demyelination in MOG-EAE and MS.
Reynolds R; Dawson M; Papadopoulos D; Polito A; Di Bello IC; Pham-Dinh D; Levine J
J Neurocytol; 2002; 31(6-7):523-36. PubMed ID: 14501221
[TBL] [Abstract][Full Text] [Related]
14. Remyelination: the true regeneration of the central nervous system.
Crawford AH; Chambers C; Franklin RJ
J Comp Pathol; 2013; 149(2-3):242-54. PubMed ID: 23831056
[TBL] [Abstract][Full Text] [Related]
15. Endogenous Nkx2.2+/Olig2+ oligodendrocyte precursor cells fail to remyelinate the demyelinated adult rat spinal cord in the absence of astrocytes.
Talbott JF; Loy DN; Liu Y; Qiu MS; Bunge MB; Rao MS; Whittemore SR
Exp Neurol; 2005 Mar; 192(1):11-24. PubMed ID: 15698615
[TBL] [Abstract][Full Text] [Related]
16. Remyelinating strategies for the treatment of multiple sclerosis.
Stangel M; Hartung HP
Prog Neurobiol; 2002 Dec; 68(5):361-76. PubMed ID: 12531235
[TBL] [Abstract][Full Text] [Related]
17. Loss of Tuberous Sclerosis Complex1 in Adult Oligodendrocyte Progenitor Cells Enhances Axon Remyelination and Increases Myelin Thickness after a Focal Demyelination.
McLane LE; Bourne JN; Evangelou AV; Khandker L; Macklin WB; Wood TL
J Neurosci; 2017 Aug; 37(31):7534-7546. PubMed ID: 28694334
[TBL] [Abstract][Full Text] [Related]
18. Identification of the Kappa-Opioid Receptor as a Therapeutic Target for Oligodendrocyte Remyelination.
Mei F; Mayoral SR; Nobuta H; Wang F; Desponts C; Lorrain DS; Xiao L; Green AJ; Rowitch D; Whistler J; Chan JR
J Neurosci; 2016 Jul; 36(30):7925-35. PubMed ID: 27466337
[TBL] [Abstract][Full Text] [Related]
19. Gain of Olig2 function in oligodendrocyte progenitors promotes remyelination.
Wegener A; Deboux C; Bachelin C; Frah M; Kerninon C; Seilhean D; Weider M; Wegner M; Nait-Oumesmar B
Brain; 2015 Jan; 138(Pt 1):120-35. PubMed ID: 25564492
[TBL] [Abstract][Full Text] [Related]
20. To what extent is oligodendrocyte progenitor migration a limiting factor in the remyelination of multiple sclerosis lesions?
Franklin RJ; Blakemore WF
Mult Scler; 1997 Apr; 3(2):84-7. PubMed ID: 9291159
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
